class action

Disc Medicine faces securities probe after FDA rejects bitopertin drug; stock slides 22% on February 13, 2026.

The Portnoy Law Firm investigates $TNDM after a 19.9% stock plunge triggered by insulin pump malfunction disclosures that could halt insulin delivery.

Law firm Robbins LLP urges $PSIX investors to act by May 19, 2026 deadline in class action alleging misleading data center projections and hidden manufacturing issues.

Portnoy Law Firm investigates $HUBG for potential securities fraud following 27% stock decline tied to disclosed accounting errors and control failures.

Pomerantz LLP investigates Banco Santander for potential securities fraud over undisclosed UK lender collapse, with stock falling 7.57% over two trading sessions.

Pomerantz Law Firm investigates potential securities fraud at Babcock & Wilcox following allegations linking a major power contract to its largest shareholder.

Portnoy Law Firm investigates Upstart Holdings for securities fraud following November 5 disclosure that its Model 22 underwriting system underperformed, causing sharp stock decline and investor losses.

Bragar Eagel & Squire investigates Arq Inc. ($ARQ) after 49% stock collapse following missed earnings, weak guidance, and unexpected production halt.

Law firm investigates HCB Financial's merger with Independent Bank, questioning fairness of 1.59 share-plus-$17.51 cash consideration to shareholders.

Federal court certifies class action against Biogen for alleged 2021 securities misrepresentations, affecting purchasers during June-July period.

Trip.com faces securities class action over antitrust risk disclosure failures. Stock fell 19.4% after China announced investigation; lead plaintiff deadline set for May 11, 2026.

Law firm Robbins LLP investigates Apollo Global Management for failing to disclose leadership's Jeffrey Epstein communications, following February 2026 media reports that triggered significant stock decline.

Monteverde & Associates investigates four mergers including $TALK's $5.25/share sale to UHS, plus deals involving $ALIS, $JTAI, and $RLYB.

Portnoy Law Firm investigates Novo Nordisk for possible securities fraud after CagriSema obesity drug failed trial, triggering 16.43% stock decline.

Camping World ($CWH) stock fell 16.5% after disappointing Q4 2025 earnings and dividend suspension. Class action lawsuit alleges misleading statements; May 11, 2026 deadline for lead plaintiff.

Portnoy Law Firm probes potential securities fraud at $GPK, examining whether board breached fiduciary duties amid recent executive leadership upheaval.

Mattel stock crashed 25% after missing 2025 guidance with flat sales and $620M operating income versus $700-750M target. Securities probe launched.

Mattel shares crashed 25% after missing 2025 guidance. Adjusted operating income fell to $620M versus $700-750M expected. Portnoy Law Firm launches securities fraud investigation.

Portnoy Law Firm investigates Western Alliance after 10.81% stock drop following disclosure of borrower fraud involving forged policies and loan breaches.

Portnoy Law Firm investigates Bausch + Lomb over TASS-linked intraocular lens recalls and significant stock declines following Q1 2025 guidance miss.